Novavax Back On Track To Begin US Trial Of COVID-19 Vaccine This Month

Supported by

After delaying its US trial by roughly a month, Novavax Inc is back on track to begin the late-stage study of its experimental coronavirus vaccine later this month.

The company said that the vaccine, NVX-CoV2373 has been given a ‘fast-track’ status from the US Food and Drug Administration and that it expected data from the trial could support US authorisation and approval, reported The Times of India.

The trial was postponed last month due to delays in scaling up the manufacturing process.

Many other companies are also testing their experimental coronavirus vaccines in late-stage studies. Pfizer Inc. said on Monday that its experimental COVID-19 vaccine was more than 90 per cent effective, citing an early data from a large-scale clinical trial.

Fast-track status allows companies to submit sections of a marketing application on a rolling basis as soon as some data becomes available, rather than wait for all the data before seeking approval.

Novavax said that a Phase II vaccine trial in South Africa has reached 50 per cent of its enrollment target. It’s UK trial has enrolled 60 per cent of its intended participants, it said.

Novavax has received $1.6 billion from the US government’s Operation Warp Speed program to speed the development and manufacturing of coronavirus vaccines and therapies. The funds will allow the company to conduct advanced human studies of its two-shot regimen, and establish manufacturing to deliver 100 million doses as soon as late 2020.

Also Read: Infant Mortality Rising Again After Demonetisation: New Study

#PoweredByYou We bring you news and stories that are worth your attention! Stories that are relevant, reliable, contextual and unbiased. If you read us, watch us, and like what we do, then show us some love! Good journalism is expensive to produce and we have come this far only with your support. Keep encouraging independent media organisations and independent journalists. We always want to remain answerable to you and not to anyone else.

Leave a Reply

Your email address will not be published. Required fields are marked *

Featured

Amplified by

P&G Shiksha

P&G Shiksha Turns 20 And These Stories Say It All

Amplified by

Isha Foundation

Sadhguru’s Meditation App ‘Miracle of Mind’ Hits 1 Million Downloads in 15 Hours, Surpassing ChatGPT’s Early Growth

Recent Stories

US Supreme Court Allows Trump Admin to Lay Off 1,400 Education Dept Staff, Halving Workforce

PU LLB 2025 Result Declared by Panjab University: Step-by-Step Guide to Check Scores & Next Steps

Double Glory for Bihar: U18 Boys Beat Odisha 17-15, Join Girls in Historic Rugby Championship Sweep

Contributors

Writer : 
Editor : 
Creatives :